Submission Guidelines

Opinion pieces and commentary

The Cancer Letter welcomes submissions of opinion pieces and commentary on policy and clinical matters:

Historically, Guest Editorials and Trials & Tribulations pieces have run between 500 and 10,000 words. There is no minimum or maximum word limit, though most fall between 750 and 1,500 words. Both are candidates for being featured on the cover. Tables, figures, and slides are welcome, as are references and endnotes.

Please provide professional headshots as well as full titles, institutional affiliations, and degree abbreviations for all authors.

Past contributors are listed here

In both Guest Editorials and Trials & Tribulations, any conflicts of interest are the responsibility of the author to disclose. These articles, which will not be peer reviewed, must adhere to our editorial and ethics policies.

The Cancer Letter is a news publication, not a scientific journal. Any submissions will be treated as opinion pieces. Rough drafts and broad ideas are welcome—most commentaries start as an informal phone call.

To inquire about submitting a Guest Editorial or a Trials & Tribulations column, contact editor Paul Goldberg (paul@cancerletter.com, 202-362-1809 ext 2).

If selected, our team will guide the editorial process.

Press releases & announcements

The Cancer Letter accepts news items for our weekly news digest summary. You may submit press releases and other announcements to be published in the following sections:

  • In Brief: Notices of academic or administrative appointments, recruitments, dedications of facilities, and forging of alliances between institutions
  • Drugs & Targets: Regulatory i.e. FDA approvals, and business developments i.e. translational R&D agreements between entities
  • Clinical Roundup: Clinical news e.g. results of clinical trials, publication of clinical guidelines, basic science discoveries etc.
  • Funding Opportunities: Available research funding and prizes

To submit, please add news@cancerletter.com to your distribution list.

RETURN TO HOMEPAGE